MarketBeat
05 Nov 2026, 04:18 UTC · 2d ago
What Sera Prognostics (SERA) Said on Its Q3 Earnings Call
Impact · against what's priced in
Sera Prognostics shows strong early momentum from Medicaid coverage in Florida and Illinois, with a significant cash runway and operational cost controls. The key catalyst is the transition from initial provider interest to broad adoption, which management expects to build by the second half of 2027.
- SERA+0.60
No priced-in read yet
- In context
Test volumes grew 54% sequentially and fivefold since Q1, supported by Medicaid coverage in IL/FL and a $450 reimbursement rate in Florida. A $72.8 million cash balance provides a runway into 2029, while an 11% sequential drop in OpEx suggests improved fiscal discipline.
Read from the article alone
